cloning 4: 119
deep brain stimulation 1: 250
dyskinesia 1: 252
ectropion 1: 87
integumentary system 1: 127
memory and memory
impairment 1: 262
midbrain 1: 232
nervous system 1:217–219
neurotransmitter 1: 272
pallidotomy 1: 274
proprioception 1:350–351
seborrheic dermatitis 1: 151
smell and taste disturbances
1: 53
swallowing disorders 1: 56
thalamotomy 1: 286
paronychia 1:180, 181 t. See also
whitlow
paroxysmal atrial tachycardia (PAT)
2: 77 , 94, 94 , 94,94, 101
paroxysmal supraventricular
tachycardia (PSVT). See
paroxysmal atrial tachycardia
partial combined immunodeficiency
(PCID) 2:289
passive immunity 2: 274 , 289, 294
Pasteur, Louis 4:1, 258
PAT. Seeparoxysmal atrial
tachycardia
Patau’s syndrome 1:350; 4:114,
117 , 136, 136 t
patellofemoral syndrome
1:348–349
patent ductus arteriosus (PDA)
2:38, 40, 64
pathogen 2:348
antibody-mediated immunity
2: 246
bacteria 2:311–312
BALT 2: 251
body substance isolation 4: 358
electrocution 4: 372
emergency and first aid 4: 356
fungus 2:327
gunshot wounds 4: 377
head and spinal cord injuries
4: 378
immune system 2: 236
immunization 2: 338
incubation period 2: 338
infection 2: 338
lymph node 2: 151
motor vehicle accidents 4: 378
multiple trauma 4: 379
phagocytosis 2: 162
pneumonia 2: 221
prion 2:349–350
protozoa 2: 350
puncture wound 4: 367
radiation and biochemical
injuries 4: 386
responder safety and personal
protection 4: 358
transmission modes 2:358
traumatic amputation 4: 380
vaccine 2: 298
virus 2:361–362
patient controlled analgesia (PCA)
1:367, 384; 4:274, 276
PBSC. Seeperipheral blood stem
cells
PCA. Seepatient controlled
analgesia
PDA. Seepatent ductus arteriosus
PDE inhibitors. See
phosphodiesterase inhibitors
peak level 4:168, 172 , 173
pediculosis 1:180–182
Pediculussp. 1:181, 182
peer pressure 4:250, 315 , 348
pellagra 4:198–199, 199 t, 205
pelvic examination 3: 259 , 316–317
pelvic inflammatory disease (PID)
2:317, 330; 3: 222 , 317, 317 t, 347
pemphigus 1:182–183
penicillin 2:308, 327, 330, 349,
356; 4:79, 80
penis 3:317–318, 318 t
balanitis 3: 248
chordee 3: 262
circumcision 3: 263
ejaculation 3: 272
erectile dysfunction 3: 278
erection 3: 278
gonnorhea 2: 330
HPV 2: 336
paraphimosis 3: 315
Peyronie’s disease 3: 318
phimosis 3: 319
priapism 3: 327
urinary system 3: 173
peptic ulcer disease 1: 42 t;2:20,
287; 3: 53 , 81–82,94; 4: 74
peptide
ACTH 3: 110
ADH 3: 113
appetite 4: 178
calcitonin 3: 115
chorionic gonadotropin 3: 115
CRH 3: 115
dopamine 3: 124epinephrine 3: 125
FSH 3: 127
GH 3: 131
GHRH 3: 131
glucagon 3: 128
GnRH 3: 129
hormone 3:134, 135
hypothalamus 3: 144
inhibin 3: 148
insulin 3: 148
LH 3: 151
melatonin 3: 151
norepinephrine 3: 152
nutrients 4: 192
oxytocin 3: 152
pineal gland 3: 154
prolactin 3: 157
relaxin 3: 158
renin 3: 158
somatostatin 3: 158
T 4 3: 166
thymosin 3: 160
TRH 3: 166
TSH 3: 164
T 3 3: 166
percutaneous liver biopsy 3: 25 , 82
performance-enhancing substances
4:348
pericarditis 2:95–96, 110
pericardium 2:4, 91, 95–96, 96,
110
perimenopause 3: 301 , 318
periodontal disease 1: 25 , 44; 4: 176
peripheral blood stem cells (PBSC)
2:122, 129, 132, 133, 159
peripheral nerves 1:276, 364 , 365
peripheral nervous system 1:215,
246–247, 276–277,284, 361
peripheral neurotransmitters
1:255, 270–271, 279, 284, 317,
350, 367
peripheral vascular disease (PVD)
1:143, 275; 2:96–97
angioplasty 2: 13
atherosclerotic plaque 2: 22
diabetes and cardiovascular
disease 2: 49
ginkgo biloba 4: 71
healing 2: 266
hyperlipidemia 2:64–65
intermittent claudication 2: 69
medications to treat
cardiovascular disease 2: 78
obesity and cardiovascular
disease 2: 90
obesity and health 4: 301496 Index